- Home
- SCLX vs EDRY Comparison
SCLX vs EDRY Comparison
Compare SCLX & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- EDRY
- Stock Information
- Founded
- SCLX 2011
- EDRY 2018
- Country
- SCLX United States
- EDRY Greece
- Employees
- SCLX N/A
- EDRY N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- EDRY Marine Transportation
- Sector
- SCLX Health Care
- EDRY Consumer Discretionary
- Exchange
- SCLX Nasdaq
- EDRY Nasdaq
- Market Cap
- SCLX 28.4M
- EDRY 24.6M
- IPO Year
- SCLX N/A
- EDRY N/A
- Fundamental
- Price
- SCLX $4.67
- EDRY $9.00
- Analyst Decision
- SCLX Strong Buy
- EDRY
- Analyst Count
- SCLX 4
- EDRY 0
- Target Price
- SCLX $396.67
- EDRY N/A
- AVG Volume (30 Days)
- SCLX 206.3K
- EDRY 3.1K
- Earning Date
- SCLX 05-23-2025
- EDRY 05-23-2025
- Dividend Yield
- SCLX N/A
- EDRY N/A
- EPS Growth
- SCLX N/A
- EDRY N/A
- EPS
- SCLX N/A
- EDRY N/A
- Revenue
- SCLX $56,590,000.00
- EDRY $61,083,227.00
- Revenue This Year
- SCLX $115.30
- EDRY N/A
- Revenue Next Year
- SCLX $73.33
- EDRY $42.57
- P/E Ratio
- SCLX N/A
- EDRY N/A
- Revenue Growth
- SCLX 21.07
- EDRY 28.35
- 52 Week Low
- SCLX $3.60
- EDRY $8.00
- 52 Week High
- SCLX $80.50
- EDRY $24.84
- Technical
- Relative Strength Index (RSI)
- SCLX 39.15
- EDRY 48.02
- Support Level
- SCLX $3.92
- EDRY $8.50
- Resistance Level
- SCLX $6.13
- EDRY $9.22
- Average True Range (ATR)
- SCLX 0.69
- EDRY 0.12
- MACD
- SCLX 0.13
- EDRY 0.11
- Stochastic Oscillator
- SCLX 32.56
- EDRY 70.67
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.